These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


369 related items for PubMed ID: 16706268

  • 1. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
    Rajkumar SV, Dispenzieri A, Kyle RA.
    Mayo Clin Proc; 2006 May; 81(5):693-703. PubMed ID: 16706268
    [Abstract] [Full Text] [Related]

  • 2. Neurologic aspects of plasma cell disorders.
    Sobol U, Stiff P.
    Handb Clin Neurol; 2014 May; 120():1083-99. PubMed ID: 24365373
    [Abstract] [Full Text] [Related]

  • 3. Neuromuscular disorders associated with paraproteinemia.
    Hoffman-Snyder C, Smith BE.
    Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):61-79, vi. PubMed ID: 18194750
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Rajkumar SV, Lacy MQ, Kyle RA.
    Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
    [Abstract] [Full Text] [Related]

  • 5. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
    Fend F, Dogan A, Cook JR.
    Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
    [Abstract] [Full Text] [Related]

  • 6. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM, Johns GS.
    Contrib Nephrol; 2007 Jan; 153():44-65. PubMed ID: 17075223
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
    Tedeschi A, Conticello C, Rizzi R, Benevolo G, Laurenti L, Petrucci MT, Zaja F, Varettoni M.
    Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
    [Abstract] [Full Text] [Related]

  • 8. Review of peripheral neuropathy in plasma cell disorders.
    Silberman J, Lonial S.
    Hematol Oncol; 2008 Jun; 26(2):55-65. PubMed ID: 18324611
    [Abstract] [Full Text] [Related]

  • 9. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group.
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [Abstract] [Full Text] [Related]

  • 10. Systemic manifestations of monoclonal gammopathy.
    Decaux O, Laurat E, Perlat A, Cazalets C, Jego P, Grosbois B.
    Eur J Intern Med; 2009 Sep; 20(5):457-61. PubMed ID: 19712843
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and management of multiple myeloma and related disorders.
    Kyle RA.
    Prog Hematol; 1986 Sep; 14():257-82. PubMed ID: 2418463
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic criteria of multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [Abstract] [Full Text] [Related]

  • 13. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
    Gnemmi V, Leleu X, Provot F, Moulonguet F, Buob D.
    Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
    [Abstract] [Full Text] [Related]

  • 14. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
    Graziani MS, Merlini G.
    Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR.
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal gammopathy and neuropathy.
    Lozeron P, Adams D.
    Curr Opin Neurol; 2007 Oct; 20(5):536-41. PubMed ID: 17885441
    [Abstract] [Full Text] [Related]

  • 17. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.
    N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA.
    Clin Chem; 2005 May 21; 51(5):878-81. PubMed ID: 15774572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.